Largest one day gains
The 50 largest one day percentage moves higher recorded at the latest close. The largest moves were BHVN at +17.9% and 0QF.DE at +15.0%. By size, the list splits into 4 mega cap, 19 large cap and 27 mid cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +17.87% | +8.65% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +14.97% | +550.51% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +13.79% | +50.11% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | +9.78% | −2.24% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +7.83% | +1112.03% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +7.20% | +156.37% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +7.20% | +394.99% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +6.68% | +96.28% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | +6.51% | −42.63% |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | +5.66% | −25.94% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +5.58% | +64.11% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +5.53% | +27.27% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | +5.45% | −20.60% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +5.22% | +26.78% |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +4.91% | +7.91% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +4.69% | +358.21% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +4.61% | +12.31% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +4.37% | +67.21% |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +4.28% | +48.91% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +4.11% | +14.09% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +4.11% | +173.39% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +3.98% | +36.19% |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | +3.89% | −29.08% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +3.89% | +61.26% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | +3.85% | −11.12% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +3.64% | +169.17% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +3.60% | +1.03% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +3.50% | +113.13% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +3.49% | +15.22% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +3.45% | +145.34% |
| U1HS34.SA | Universal Health Services, Inc. | $10.55B | Large cap | +3.39% | −6.44% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +3.30% | +219.58% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | +3.30% | −30.11% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +3.28% | +129.80% |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +3.21% | +54.91% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +3.18% | +65.32% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +3.07% | +74.18% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +3.05% | +90.31% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +3.05% | +29.71% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +3.02% | +5.65% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +3.01% | +5.41% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +2.91% | +57.99% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | +2.86% | −11.26% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +2.85% | +7.69% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +2.83% | +269.13% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +2.74% | +8.99% |
| ARGX | argenx SE | $65.51B | Large cap | +2.71% | +47.90% |
| MDLN | Medline Inc. | $46.53B | Large cap | +2.71% | −13.07% |
| DVAI34.SA | DaVita Inc. | $11.70B | Large cap | +2.70% | +18.80% |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +2.61% | +6.22% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.